ACG Postgraduate Course at 2024 Annual Meeting

ACG Annual Postgraduate Course: Evidence-Based Updates for Today’s Clinical Practice

Course Directors: Jodie A. Barkin, MD, FACG, and Jill K. J. Gaidos, MD, FACG

7:55 am Introduction by Course Directors
8:00 am Session 2A: Esophageal Disorders
Moderator: Nicholas J. Shaheen, MD, MPH, MACG
  • NERD, GERD, and Everything in Between
    Christine Y. Hachem, MD, FACG
    Discuss a practical approach to the evaluation and management of heartburn, reflux, and atypical chest pain, including the management of PPI-refractory patients and anti-reflux therapies.
  • Barrett’s Esophagus: Screening, Surveillance, Ablate or Resect?
    Nicholas J. Shaheen, MD, MPH, MACG
    Review the current recommendations for the evaluation and management of Barrett’s esophagus.
  • Esophageal Motility Disorders: Common Presentations, Testing Modalities, and Treatments
    Jennifer Horsley-Silva, MD
    Provide an overview of the various esophageal motility disorders with their evaluation and management including indications for the use of EndoFLIP and high-resolution manometry.
  • Eosinophilic Esophagitis: Updates From the ACG Guidelines
    Evan S. Dellon, MD, MPH, FACG
    Highlight the key recommendations for the evaluation and management of eosinophilic esophagitis based on the recent ACG guidelines.
  • Panel Q & A
9:40 am Break
10:00 am Session 2B: Personalizing IBD Therapy to Improve Outcomes
Moderator: Jill K. J. Gaidos, MD, FACG
  • Positioning IBD Therapies for UC: Where to Start and When to Switch
    David T. Rubin, MD, FACG
    Review the current evidence to support optimal positioning of the available ulcerative colitis therapies and when to move on to the next treatment option.
  • Management of Complex Crohn’s Disease
    Miguel D. Regueiro, MD, FACG
    Discuss current evidence-based strategies for treating complex or refractory Crohn’s disease including recommendations for post-operative management.
  • Risks of Adverse Side Effects With New IBD Therapies: Selecting Treatment Based on

    Millie D. Long, MD, MPH, FACG
    Provide an overview of the potential adverse side effects of the newest IBD therapies and how they may impact medication selection.
  • Role of Therapeutic Drug Monitoring in Today’s IBD Practice
    Jill K. J. Gaidos, MD, FACG
    Highlight the continued role for therapeutic drug monitoring in the current management of IBD patients.
  • Colonic Dysplasia in IBD: Surveil or Resect?
    Samir A. Shah, MD, FACG
    Explore the updated guidelines on CRC surveillance in IBD including the role of endoscopic therapy vs surgical resection.
  • Panel Q & A
12:00 pm Break for Learning Luncheons
12:20 pm –
1:35 pm
Sunday Optional Learning Luncheon Bonus Sessions

ACG has combined the popular in-person Learning Luncheons with on-demand access to the pre-recorded lectures for ALL 24 Learning Luncheon Bonus Sessions. Add this optional package to your Postgraduate Course registration for even more first-class education that provides an additional 18 hours of CME/MOC credit!

You must register for the Postgraduate Course in order to purchase the optional Learning Luncheon Bonus Sessions package. Both in-person and virtual registrants can purchase this add-on package. In-person attendees purchasing the package will be able to select a Saturday and a Sunday luncheon presentation to attend during the registration process.

  1. Health Disparities Among Patients With Chronic Liver Diseases
    Fasiha Kanwal, MD, MSHS
    Discuss the prevalence of health inequities within the care of patients with chronic liver disease, and provide strategies to address these inequities to minimize their impact.
  2. How Do I Approach the Patient With Diarrhea?
    William D. Chey, MD, FACG
    Discuss the diagnostic evaluation of chronic diarrhea and management including medical therapies and diet and lifestyle interventions.
  3. Evaluating Elevated LFTs
    Vijay H. Shah, MD, FACG
    Highlight a practical approach to the evaluation of elevated liver enzymes including when to refer to a transplant center.
  4. Gastric Premalignant Conditions: Updates From the Guidelines
    Douglas R. Morgan, MD, MPH, FACG
    Provide recommendations from the recent ACG guidelines on the evaluation and treatment of gastric premalignant conditions.
  5. Elevated Pancreatic Enzymes: Incidental, Drug-Induced, Pathogenic, or Autoimmune?
    Vikesh K. Singh, MD, MSc
    Describe the evaluation of a patient with elevated pancreatic enzymes, and explore treatment strategies for the different potential etiologies responsible for this elevation.
  6. Cannabis for Gastrointestinal Disorders: Everything You Wanted to Know, But Were Afraid to Ask
    Linda Anh B. Nguyen, MD, FACG
    Provide an overview of the endocannabinoid system and identify the role of cannabinoids in the treatment of disorders of gut-brain interaction and inflammatory bowel disease.
  7. Gut Dysbiosis and the Role of Fecal Microbiota Transplantation in GI Disorders
    Jessica R. Allegretti, MD, MPH, FACG
    Discuss gut dysbiosis and microbiome interventions in disorders of the GI tract.
  8. Advancing Your Colonoscopy Skills: Integrating EMR, Water Colonoscopy, and CO2 Into Your Everyday Practice
    Mark B. Pochapin, MD, FACG
    Describe practical tips and evidenced-based recommendations for improving adenoma detection and resection during colonoscopy.
  9. Optimizing Diagnosis and Therapy of H. pylori: An ACG Guidelines-Based Approach
    Shailja C. Shah, MD, MPH
    Discuss the diagnosis and management of H. pylori, including treatment failures and refractory disease, focusing on updates from the recent ACG guidelines.
  10. Management of Intra-Abdominal and Perianal Abscesses and Fistulae in Crohn’s Disease: Antibiotics, Biologics, Drainage, or Surgery?
    Andres J. Yarur, MD, FACG
    Highlight evidence-based recommendations for the management of complications of Crohn’s disease.
  11. Revenge of the Cheesesteak: Foreign Bodies, Food Impactions, and Other Fun Middle of the Night Calls
    Melissa Latorre, MD, MS
    Differentiate the use of various endoscopic tools and techniques for the treatment of foreign body ingestion and food impactions.
  12. ERCPs: How to Make Difficult Biliary Cannulations Easier and Minimize Your Pancreatitis Risk
    Allison R. Schulman, MD, MPH
    Review practical tips for performing ERCP in difficult cases while minimizing the risk for complications, and compare the data on post-ERCP pancreatitis preventative strategies including medical therapies, intravenous fluids, and pancreatic stenting.
1:35 pm Break
1:45 pm –
3:00 pm
Simultaneous Symposia

Symposium D: New Innovations in Endoscopy
Moderator: Seth A. Gross, MD, FACG

  • Integrating Artificial Intelligence into CRC Screening to Improve Visualization and Characterization
    Seth A. Gross, MD, FACG
    Describe how AI can be a useful clinical tool to improve adenoma detection rates and reduce interval colon cancers.
  • Splitting the Wall: Updates on Submucosal and Full-Thickness Endoscopy
    Peter V. Draganov, MD, FACG
    Illustrate the indications for and newest data on various endoscopic tunneling and resection techniques including POEM, ESD, and EFTR.
  • Punching Through the Wall: Lumen-Apposing Metals Stents - Where Can We Go?
    Amrita Sethi, MD
    Discuss the appropriate clinical scenarios for the use of lumen-apposing stents including both endoscopic drainage and endoscopic access procedures.
  • Panel Q & A

Symposium E: Abdominal Distention: Dysmotility, Dysbiosis, or Diet?
Moderator: Baharak Moshiree, MD, MSc, FACG

  • Gastroparesis: Diagnosis, Medical and Endoscopic Therapies
    Baharak Moshiree, MD, MSc, FACG
    Describe evidence-based approaches to the evaluation and treatment of gastroparesis including dietary modifications, medications, and endoscopic therapy.
  • SIBO, Disaccharidase Deficiencies, Foods, and Functional – What Do I Do?
    Brooks D. Cash, MD, FACG
    Illustrate the different causes of bloating, when to consider further evaluation, and provide an overview of treatment options as part of a practical diagnostic approach.
  • Celiac Disease – What’s New and What’s on the Horizon
    Amy S. Oxentenko, MD, FACG
    Highlight key updates in the evaluation and management of celiac disease.
  • Panel Q & A

Symposium F: Non-IBD Infectious and Inflammatory Colidities
Moderator: David J. Hass, MD, FACG

  • Diagnosis and Treatment of Clostridioides difficile and Recurrent

    Neil H. Stollman, MD, FACG
    Outline current and future therapies for initial and refractory C. difficile infection including antibiotics, fecal microbial transplantation, and biologics.
  • Diverticulitis, SCAD, and Epiploic Appendagitis: What’s New?
    David J. Hass, MD, FACG
    Describe the clinical presentations, diagnosis, and treatment of various common colonic conditions with a focus on updated recommendations.
  • When Immunotherapy Goes Wrong: Management of Gastrointestinal, Pancreatic, and Hepatic Toxicities
    Shilpa Grover, MD, MPH
    Provide guidance on the evaluation and treatment for adverse GI side effects from immunotherapy.
  • Panel Q & A
3:00 pm Break / Exhibit Hall Opens
3:20 pm Session 2C: Colon Cancer Screening and Management of Colon Polyps
Moderator: Aasma Shaukat, MD, MPH, FACG
  • CRC Screening: When to Start, What Modality to Use, When to Stop
    Aasma Shaukat, MD, MPH, FACG
    Discuss the recent colon cancer screening guidelines for how best to screen, when to start, and when to stop.
  • Optimizing Colonoscopy Performance: Tips and Tricks to Improve Quality
    Douglas K. Rex, MD, MACG
    Describe practical tips and evidenced-based recommendations for improving prep quality, adenoma detection, and complete polyp resection.
  • Resecting Colon Polyps: Snare, EMR, or ESD?
    Shivangi T. Kothari, MD, FACG
    Illustrate various techniques for complete polyp resection based on polyp type, size, and location.
  • Panel Q & A
4:40 pm Take-Home Pearls: What Did We Learn Today?
Jodie A. Barkin, MD, FACG, and Jill K. J. Gaidos, MD, FACG
Review important and practical take-home messages from today’s talks.
5:00 pm Postgraduate Course Adjourns